Related Experiment Video

Updated: Aug 15, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential

Douglas M Molina1, Seema Grewal, Lee Bardwell

  • 1Department of Developmental and Cell Biology, University of California, Irvine, California 92697, USA.

The Journal of Biological Chemistry
|October 26, 2005
PubMed

Insights

Mitogen-activated protein kinases (MAPKs) bind substrates like microphthalmia-associated transcription factor (MITF) via specific docking sites. This interaction allows for targeted kinase inhibition, offering a new therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Mitogen-activated protein kinases (MAPKs) mediate crucial cellular processes.
  • Docking sites enhance the specificity and efficiency of MAPK signaling pathways.
  • Microphthalmia-associated transcription factor (MITF) is a key substrate regulated by MAPKs.

Purpose of the Study:

  • To investigate the molecular basis of ERK1/ERK2 and MITF interaction.
  • To identify the specific domain within MITF responsible for ERK binding.
  • To explore the potential for substrate-selective kinase inhibition.

Main Methods:

  • Co-immunoprecipitation assays to detect ERK-MITF complex formation.
  • Site-directed mutagenesis of MITF to identify the ERK-binding domain.
  • Kinase assays using wild-type and mutant MITF to assess phosphorylation efficiency.
  • Competitive inhibition assays using D-site peptides.

Main Results:

  • ERK1 and ERK2 form a stable complex with MITF (Kd ~6 µM).
  • A ~100-residue domain C-terminal to Ser73 in MITF is essential for ERK binding.
  • MITF mutants lacking this domain show reduced ERK2 binding and phosphorylation.
  • D-site peptides selectively inhibit Elk-1 phosphorylation over MITF phosphorylation (>15-fold selectivity).

Conclusions:

  • The ERK-binding domain of MITF is a novel docking motif, distinct from known D-sites.
  • ERK-MITF interaction is independent of the ERK2 CD/sevenmaker region.
  • These findings demonstrate substrate-selective kinase inhibition via targeted disruption of docking interactions.
  • This opens possibilities for developing small molecules to selectively modulate specific MAPK substrates.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence09:58

An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence

Published on: May 2, 2025

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...